Article Versions Notes

Tsouri S, Tselo E, Premetis GE, Furlan V, Pantiora PD, Mavroidi B, Matiadis D, Pelecanou M, Papageorgiou AC, Bren U, et al. A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide. Pharmaceuticals. 2024; 17(3):365. https://doi.org/10.3390/ph17030365

Tsouri, Steliana, Evanthia Tselo, Georgios E. Premetis, Veronika Furlan, Panagiota D. Pantiora, Barbara Mavroidi, Dimitris Matiadis, Maria Pelecanou, Anastassios C. Papageorgiou, Urban Bren, and et al. 2024. "A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide" Pharmaceuticals 17, no. 3: 365. https://doi.org/10.3390/ph17030365

Tsouri, S., Tselo, E., Premetis, G. E., Furlan, V., Pantiora, P. D., Mavroidi, B., Matiadis, D., Pelecanou, M., Papageorgiou, A. C., Bren, U., Sagnou, M., & Labrou, N. E. (2024). A Monocarbonyl Curcuminoid Derivative Inhibits the Activity of Human Glutathione Transferase A4-4 and Chemosensitizes Glioblastoma Cells to Temozolomide. Pharmaceuticals, 17(3), 365. https://doi.org/10.3390/ph17030365